OverviewSuggest Edit

Oncoinvent AS is a privately held Norwegian company and is based in Oslo, Norway. The company is committed to developing new innovative products in order to provide better treatment options to cancer patients. The company's founders started Oncoinvent in 2010 with a view to designing better cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns. This approach has allowed the company to develop a rich development pipeline and to explore multiple technological avenues before selecting a lead product candidate for preclinical testing.

Latest Updates

Employees (est.) (Feb 2020)24

Key People/Management at Oncoinvent

Jan Alfheim

Jan Alfheim

Ole Nordby

Ole Nordby

Oyvind Bruland

Oyvind Bruland

Tina Bonsdorff

Tina Bonsdorff

Show more

Oncoinvent Financials and Metrics

Summary Metrics

Founding Date


Oncoinvent total Funding

$25 m

Oncoinvent latest funding size

$25 m

Time since last funding

3 years ago

Oncoinvent investors

Oncoinvent's latest funding round in February 2017 was reported to be $25 m. In total, Oncoinvent has raised $25 m
Show all financial metrics

Oncoinvent Online and Social Media Presence

Embed Graph

Oncoinvent Frequently Asked Questions

  • When was Oncoinvent founded?

    Oncoinvent was founded in 2010.

  • Who are Oncoinvent key executives?

    Oncoinvent's key executives are Jan Alfheim, Ole Nordby and Oyvind Bruland.

  • How many employees does Oncoinvent have?

    Oncoinvent has 24 employees.

  • Who are Oncoinvent competitors?

    Competitors of Oncoinvent include Fresenius Kabi, Anchiano Therapeutics and Nuo Therapeutics.